Diagnostyka S.A. provides diagnostic services in Poland. The company operates as a medical laboratory, which offers services, such as ultrasound, X-ray, computed tomography, and magnetic resonance imaging. It also offers specialized research in the field of microbiology, autoimmunity, toxicology, and molecular biology, as well as human genome research, histopathological examinations, immunohistochemical tests, cytological tests, and cytogenetic tests. The company provides services to individual clients, and public and private entities. Diagnostyka S.A. was founded in 1998 and is headquartered in Kraków, Poland.
Frequently asked questions
What sector does Diagnostyka S.A. (DIA) operate in?
Diagnostyka S.A. belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is Diagnostyka S.A. (DIA) current stock price?
As of the latest data, Diagnostyka S.A. stock price is PLN 169.70, with a previous close of PLN 170.10. Diagnostyka S.A. lost -PLN 0.40 in the last trading session, representing a -0.24% loss.
What is Diagnostyka S.A. (DIA) current market capitalization?
Diagnostyka S.A. market cap is approximately 5.73 billion.
What is Diagnostyka S.A. (DIA) Earnings Per Share (EPS)?
The trailing EPS is PLN 7.75, and the forward EPS is PLN 9.95.
What is Diagnostyka S.A. (DIA) Price-to-Earnings (P/E) ratio?
Diagnostyka S.A. current P/E ratio is 21.9, with a forward P/E of 17.05.
Does Diagnostyka S.A. (DIA) pay dividends?
Yes. Diagnostyka S.A. pays annual dividends with an annualized yield of 2.59% and an estimated annual payout of PLN 4.40 per share.
When is the next ex-dividend date for Diagnostyka S.A. (DIA)?
The next ex-dividend date is scheduled for June 01, 2027.
When is Diagnostyka S.A. (DIA) next earnings report?
Diagnostyka S.A. is expected to release its next earnings report on June 30, 2026.
What is Diagnostyka S.A. (DIA) beta (volatility) score?
Diagnostyka S.A. has a beta of 0.131, indicating lower volatility than the overall market.
